Published 2026-09-16 · Last reviewed 2026-09-16 · By Andy Palenzuela, Founder
Every NAD+ precursor eventually meets the same question: do you need to take TMG with it? Most of the answers online are written about NMN, by pages that also sell TMG as a separate bottle — which is a convenient conclusion for a two-bottle business. This article explains where nicotinamide riboside (NR) and methylation actually intersect, what is established biochemistry versus what is hypothesis, and why TMG on its own is only part of the co-factor picture.
It is written by the founder of Age Revive, who spent 14+ years inside regulated nutrition supply chains before formulating CELLUNAD+.
Your body runs millions of reactions that require adding a single carbon atom, in the form of a methyl group, to something else. Methyl groups switch genes on and off, help build neurotransmitters, and tag molecules for excretion. The universal donor for these reactions is S-adenosylmethionine (SAMe).
Every time SAMe donates a methyl group, it becomes S-adenosylhomocysteine and then homocysteine. Homocysteine has to be recycled back into methionine (to make more SAMe) or shunted out of the cycle. That recycling is where the B vitamins and betaine come in:
If methyl demand goes up and the cycle is not resupplied, homocysteine tends to rise. That is the entire reason "methylation support" appears on NAD+ labels.
NR is a precursor: it is converted to NMN, and NMN is converted to NAD+. That part is well mapped. Human studies have shown oral NR raises blood NAD+ metabolites in a dose-dependent way (Trammell 2016; Conze 2019).
What gets less attention is the back half of the story. NAD+ is not a battery you fill once. Enzymes such as sirtuins, PARPs, and CD38 consume it continuously, and each consumption event releases nicotinamide (NAM). The body has two main ways to handle NAM:
Route 2 spends a methyl group. The NAD+ metabolome measured in human NR studies includes these methylated nicotinamide products (Trammell 2016), which tells you the clearing route is active when NR is taken.
So the reasoning goes: supplying more precursor raises NAD+ throughput, more NAD+ turnover produces more NAM, and more NAM clearance draws down methyl donors. That is the mechanism behind every "take TMG with your NAD+" recommendation.
Being precise here matters more than being persuasive.
Established:
Hypothesis (mechanistically reasonable, not proven in a human trial):
That NR supplementation at supplement doses meaningfully depletes methyl donors in healthy adults.
That co-supplementing TMG with NR changes any measured outcome.
That there is a "correct" TMG-to-NR ratio. Ratios circulating online are extrapolations, not trial results.
The honest position: including methylation co-factors alongside NR is a low-risk formulation decision that addresses a plausible demand. It is not a proven requirement, and any brand telling you TMG is "required for NR to work" is overstating the evidence.
Here is the part the NMN + TMG articles skip. Look at the cycle again. Betaine only feeds one of the two homocysteine-remethylation routes. The other route — methionine synthase — needs methylfolate and B12, and neither is optional. Vitamin B6 handles the transsulfuration exit. A formula that adds TMG and stops there has supplied one door of a three-door building.
The active forms matter too. Folic acid must be converted to 5-MTHF before it can donate a methyl group; a meaningful share of people carry MTHFR variants that slow that conversion. Cyanocobalamin must be converted to methylcobalamin. Pyridoxine must be converted to pyridoxal-5'-phosphate. Using the active forms removes conversion steps from the chain.
This is the difference between a formula that mentions methylation and one that covers it.
CELLUNAD+ was formulated on the assumption that an NAD+ precursor should carry its own co-factors rather than send you to a second bottle. Each daily serving (2 capsules) contains:
| Ingredient | Amount per serving | Role in the cycle |
|---|---|---|
| Nicotinamide riboside (NR) | 500 mg | NAD+ precursor — dose informed by published human NR research |
| Betaine (TMG) | 250 mg | Methyl donor for the BHMT route |
| Folate (5-MTHF) | 400 mcg DFE | Methyl donor for the methionine-synthase route |
| Vitamin B12 (methylcobalamin) | 1,000 mcg | Cofactor for methionine synthase |
| Vitamin B6 (P-5-P) | 10 mg | Cofactor for the transsulfuration exit |
| Apigenin | 100 mg | Flavonoid researched for CD38 management |
| R-lipoic acid | 200 mg | Mitochondrial cofactor support |
| BioPerine (black pepper extract) | 5 mg | Nutrient absorption support |
Read the TMG dose for what it is: 250 mg is a co-factor amount inside an NAD+ formula, not the 6 g/day used in the homocysteine trial. It is there to support methylation balance alongside NR — not to replicate a homocysteine study.
Every dose is on the label. If you want the full comparison of NR against the other precursor, read NMN vs NR: Two NAD+ Precursors, Compared.
Do I need to take TMG with NR? Not by any published human trial. The mechanism is plausible: clearing nicotinamide from NAD+ turnover uses methyl groups. Including methylation co-factors with NR is a low-risk formulation choice, not a proven requirement.
Is TMG enough for methylation support with an NAD+ precursor? TMG supplies one of the two homocysteine-remethylation routes. The other needs methylfolate (5-MTHF) and vitamin B12; vitamin B6 (P-5-P) supports the transsulfuration exit. A complete co-factor set includes all four.
How much TMG is in CELLUNAD+? 250 mg per daily serving, alongside 500 mg NR, 400 mcg DFE 5-MTHF, 1,000 mcg methylcobalamin, and 10 mg P-5-P.
Does CELLUNAD+ lower homocysteine? CELLUNAD+ does not make that claim. Betaine has lowered plasma homocysteine in human trials at 6 g/day (Schwab 2002); the 250 mg in CELLUNAD+ is included to support methylation balance alongside NR, not to reproduce that study.
CELLUNAD+ product page · Science · FAQ · All Learn articles
Andy Palenzuela is the founder of Age Revive and has 14+ years of experience in regulated nutrition supply chains, including manufacturing oversight, ingredient sourcing, and quality assurance for consumer health products. Age Revive formulas are developed based on published peer-reviewed research and manufactured at cGMP-certified facilities. LinkedIn
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information in this article is for educational purposes only and is not intended as medical advice. Consult your healthcare provider before starting any supplement regimen.